Andy Waldeck
Andy Waldeck was named Global Managing Partner at Innosight in 2022. Over the past 15 years at Innosight, Andy has advised senior leaders at companies such as Aetna, Baxter, Covidien (now part of Medtronic), and Walgreens. He has extensive experience across the healthcare industry including payers, providers, medical devices, pharmaceuticals, pharmacies, and health information technology. Andy also has worked with other Fortune 500 companies across the media, financial services and consumer industries. At Innosight, Andy’s work focuses on helping clients to develop long-term growth strategies, manage enterprise transformation, build enduring growth and innovation capabilities and design new disruptive growth businesses Andy is a frequent speaker and author on topics of healthcare transformation, disruption and long-term growth. Andy’s experience with growth and innovation stems from his past work with early-stage growth companies as both an investment banker and venture capitalist.
